TVTX

TVTX

USD

Travere Therapeutics Inc. Common Stock

$34.510+1.910 (5.859%)

वास्तविक समय मूल्य

Healthcare
जैव प्रौद्योगिकी
संयुक्त राज्य अमेरिका

मूल्य चार्ट

Loading Chart...

मुख्य मीट्रिक्स

बाजार मीट्रिक्स
कंपनी के मौलिक सिद्धांत
ट्रेडिंग आँकड़े

बाजार मीट्रिक्स

खुलना

$32.600

उच्च

$34.605

कम

$32.310

मात्रा

0.26M

कंपनी के मौलिक सिद्धांत

बाजार पूंजीकरण

3.1B

उद्योग

जैव प्रौद्योगिकी

देश

United States

ट्रेडिंग आँकड़े

औसत मात्रा

2.25M

एक्सचेंज

NGM

मुद्रा

USD

52-सप्ताह रेंज

कम $12.91वर्तमान $34.510उच्च $36.15

संबंधित समाचार

BusinessWire

Travere Therapeutics to Participate at Upcoming Investor Conferences

Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced that company management will participate in the following upcoming investor conferences: Guggenheim's 2nd Annual Healthcare Innovation Conference Presenting

और देखें
Travere Therapeutics to Participate at Upcoming Investor Conferences
Analyst Upgrades

Piper Sandler Maintains Neutral on Travere Therapeutics, Raises Price Target to $35

Piper Sandler analyst Allison Bratzel maintains Travere Therapeutics with a Neutral and raises the price target from $26 to $35.

और देखें
Piper Sandler Maintains Neutral on Travere Therapeutics, Raises Price Target to $35
Analyst Upgrades

TD Cowen Maintains Buy on Travere Therapeutics, Raises Price Target to $40

TD Cowen analyst Tyler Van Buren maintains Travere Therapeutics with a Buy and raises the price target from $30 to $40.

और देखें
TD Cowen Maintains Buy on Travere Therapeutics, Raises Price Target to $40
BusinessWire

Travere Therapeutics to Report Third Quarter 2025 Financial Results

Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced it will report third quarter 2025 financial results on Thursday, October 30, 2025, after the close of the U.S. financial markets. The Company will host a

और देखें
Travere Therapeutics to Report Third Quarter 2025 Financial Results

अपडेट रहें

मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।